BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38251953)

  • 1. Ferroptosis heterogeneity within the tumor microenvironment revealed a genetic blueprint of breast cancer.
    Qiu Z; Deng C; Zhou F; Chen Y; Chen X; Liu X; Ye C; Jin N
    Environ Toxicol; 2024 May; 39(5):2741-2752. PubMed ID: 38251953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
    Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized machine learning based on multi-omics data to profile the effect of ferroptosis pathway on prognosis and immunotherapy response in patients with bladder cancer.
    Liu X; Qiu Z; Zhang X; Su Z; Yi R; Zou D; Xie C; Jin N; Long W; Liu X
    Environ Toxicol; 2024 Feb; 39(2):680-694. PubMed ID: 37647346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-related genes prognostic signature for pancreatic cancer and immune infiltration: potential biomarkers for predicting overall survival.
    Wang L; Wu Z; Xu C; Ye H
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18119-18134. PubMed ID: 38007403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immune infiltration landscape on prognosis and therapy of the ferroptosis-related genes signature in breast cancer.
    Chen Y; Zhao S; Kang Y; Zhang Y; Chang X
    Biochim Biophys Acta Mol Cell Res; 2022 Nov; 1869(11):119328. PubMed ID: 35901969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting prognosis and clinical features of the tumor microenvironment based on ferroptosis score in patients with breast cancer.
    Yin L; Tang Y
    Sci Rep; 2022 Jun; 12(1):10611. PubMed ID: 35739315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
    Wang F; Chen C; Chen WP; Li ZL; Cheng H
    Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-related local immune cytolytic activity in tumor microenvironment of basal cell and squamous cell carcinoma.
    Wang J; Xie D; Wu H; Li Y; Wan C
    Aging (Albany NY); 2022 May; 14(9):3956-3972. PubMed ID: 35501667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
    Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma.
    Lan T; Ren S; Hu H; Wang R; Chen Q; Wu F; Xu Q; Li Y; Shao L; Wang L; Liu X; Cao H; Li J
    Recent Pat Anticancer Drug Discov; 2024; 19(3):354-372. PubMed ID: 38214321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer.
    Zhang Y; Liang Y; Wang Y; Ye F; Kong X; Yang Q
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36222299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ferroptosis-related subtypes, characteristics of TME infiltration and development of prognostic models in gastric cancer.
    Tang X; Yu Y; Liu N; Su Y; Zhang K; Zhai Z; Chen C; Sun W; Chen D; Ling R
    Int Immunopharmacol; 2024 Mar; 130():111610. PubMed ID: 38402832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifies microtubule-binding protein
    Wang W; Zhang J; Wang Y; Xu Y; Zhang S
    Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer.
    Liu Q; Ma JY; Wu G
    Aging (Albany NY); 2021 Sep; 13(17):21385-21399. PubMed ID: 34499616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
    Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
    BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.
    Zhang L; Zhao T; Wu X; Tian H; Gao P; Chen Q; Chen C; Zhang Y; Wang S; Qi X; Sun N
    Front Immunol; 2023; 14():1264206. PubMed ID: 38152394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.